Modulation of anxiety-related behaviors by μ- And κ-opioid receptor agonists depends on the social status of mice

Peptides

Volumn 25, Issue 8, 2004, Pages 1355-1363

  Kudryavtseva, Natalia N ^a   Gerrits, Mirjam A F M ^b   Avgustinovich, Damira F ^a   Tenditnik, Michael V ^a   Van Ree, Jan M ^b  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Opioid receptors; Opioid receptor; Aggression; Anxiety; Anxiolytic; DAMGO; Mice; Opioids; Social status; Submission; U 50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR AGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MAZE TEST; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SOCIAL STATUS;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; MALE; MICE; MICE, INBRED C57BL; PLACEBOS; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SOCIAL BEHAVIOR; SOCIAL DOMINANCE;

ANIMALIA;

EID: 4444231288     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.05.005     Document Type: Article

References (33)

1. Alexander B.K., Beyerstein B.L., Hadaway P.F., Coambs R.B. Effect of early and later colony housing on oral ingestion of morphine in rats. Pharmacol. Biochem. Behav. 15(4):1981;571-576
2. Avgustinovich D.F., Gorbach O.V., Kudryavtseva N.N. Comparative analysis of anxiety-like behavior in partition and plus-maze tests after agonistic interactions in mice. Physiol. Behav. 61:1997;37-43
3. Benton D. Mu and Kappa opiate receptor involvement in agonistic behavior in mice. Pharmacol. Biochem. Behav. 23:1985;871-876
4. Benton D, Brain PF. The role of opioid mechanisms in social interaction and attachment. In: Rodgers RJ, Cooper SJ, editors. Endorphins, opiates and behavioral processes. New York: Wiley; 1988. p. 217-35.
5. Blanchard R.J., Yudko E.B., Blanchard D.C. Alcohol, aggression and the stress of subordination. J. Stud. Alcohol Suppl. 11:1993;146-155
6. Brandao M.L., Anseloni V.Z., Pandossio J.E., De Araujo J.E., Castilho V.M. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain. Neurosci. Biobehav. Rev. 23(6):1999;863-875
7. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Tomkins D.M. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol. Biochem. Behav. 32:1989;777-785
8. Fanselow M.S., Calcagnetti D.J., Helmstetter F.J. Peripheral versus intracerebroventricular administration of quaternary naltrexone and the enhancement of Pavlovian conditioning. Brain Res. 444:1988;147-152
9. File S.E., Hyde J.R. Can social interaction be used to measure anxiety? Br. J. Pharmacol. 62:1978;19-24
10. File S.E., Rodgers R.J. Partial anxiolytic action of morphine sulfate following microinjection into the central nucleus of the amygdala in rats. Pharmacol. Biochem. Behav. 11(3):1979;313-318
11. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol. Rev. Ther. 65(3):1995;319-395
12. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? Pharmacol. Rev. Ther. 82(1):1999;1-61
13. Koks S., Soosaar A., Voikar V., Bourin M., Vasar E. BOC-CCK-4, CCK(B) receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze. Neuropeptides. 33(1):1999;63-69
14. Kudryavtseva N.N. The sensory contact model for the study of aggressive and submissive behaviors in male mice. Aggr. Behav. 17:1991;285-291
15. Kudryavtseva N.N. Experience of defeat decreases the behavioral reactivity to conspecifics in the partition test. Behav. Proc. 32:1994;297-304
16. Kudryavtseva N.N. Application of the partition test in behavioral and pharmacological study. Russ. J. Physiol. 88:2002;90-105. [review]
17. Kudryavtseva N.N., Madorskaya I.A., Bakshtanovskaya I.V. Social success and voluntary ethanol consumption in mice of C57BL/6J and CBA/Lac strains. Physiol. Behav. 50:1991;143-146
18. Kudryavtseva N.N., Dolgov V.V., Avgustinovich D.F., Alekseyenko O.V., Lipina T.V., Koryakina L.A. Modifying influence of the repeated experience of agonistic confrontations on effects of naltrexone in male mice. Russ. J. Physiol. 87:2001;227-238
19. Kuzmin A.V., Semenova S., Gerrits M.A., Zvartau E.E., Van Ree J.M. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice. Eur. J. Pharmacol. 321:1997;265-271
20. Lister R.G. The use of the plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185
21. Menard J., Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev. 23(4):1999;591-613
22. Miczek K.A., Nikulina E., Kream R.M., Carter G., Espejo E.F. Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG. Psychopharmacology. 141:1999;225-234
23. Motta V., Penha K., Brandao M.L. Effects of microinjections of Mu and Kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test. Psychopharmacology. 120(4):1995;470-474
24. Nobre M.J., Ribeiro dos Santos N., Aguiar M.S., Brandao M.L. Blockade of Mu- and activation of Kappa-opioid receptors in the dorsal periaqueductal gray matter produce defensive behavior in rats tested in the elevated plus-maze. Eur. J. Pharmacol. 15(404):2000;145-151
25. Privette T.H., Terrian D.M. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze. Psychopharmacology. 118:1995;444-450
26. Rodgers R.J., Cole J.C. Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors. Physiol. Behav. 53(2):1993;383-388
27. Vaccarino A.L., Olson G.A., Olson R.D., Kastin A.J. Endogenous opiates: 1998. Peptides. 20:1999;1527-1574
28. Van Ree J.M., Gerrits M.A., Vanderschuren L.J. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol. Rev. 51:1999;341-396
29. Van Ree J.M., Niesink R.J., Van Wolfswinkel L., Ramsey N.F., Kornet M.M., Van Furth W.R., et al. Endogenous opioids and reward. Eur. J. Pharmacol. 405:2000;89-101
30. Vanderschuren L.J., Niesink R.J., Spruijt B.M., Van Ree J.M. μ- and κ-opioid receptor-mediated opioid effects on social play in juvenile rats. Eur. J. Pharmacol. 276:1995;257-266
31. Vivian J.A., Miczek K.A. Effects of Mu and delta opioid agonists and antagonists on affective vocal and reflexive pain responses during social stress in rats. Psychopharmacology. 139(4):1998;364-375
32. Wall PM, Messier C. U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice. Brain Res 2000;21:856(1-2):259-280.
33. Whitten RD, Jasnow AM, Albers HE, Martin-Schild S, Zadina JE, Huhman KL. The effects of endomorphin-1 on conditioned defeat in Syrian hamsters (Mesocricetus auratus). Brain Res (2001)28: 914(1-2):74-80.